|
Vivek Shastri, Ph.D., is a postdoctoral associate at the University of Florida’s College of Pharmacy. Prior to joining Professor Jatinder Lamba’s lab at UF, he obtained a Ph.D. in cellular and molecular biology from the University of South Florida. Currently, his research focuses on immunotherapy in AML as well as in identifying pharmacogenetic predictors of a patient’s response to immunotherapy for AML.
|
